A Study to Evaluate the Efficacy and Safety of Zanubrutinib in Chinese Adults With Treatment-Naive Waldenström Macroglobulinemia
Clinical trial NCT07169331 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT07169331
- Sponsor
- BeiGene
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2025-10-17
- Primary completion
- 2028-10-31
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.